Parathyroid tumours often demonstrate over-expression of cyclin D1, thus making the p16ink4A gene an interesting candidate for promoter methylation assays since p16ink4A inactivation might produce parallel oncogenic effects analogous to cyclin D1 up-regulation [17]. Here, CDKN2A is linked to tumor of parathyroid gland.